8-K: Phreesia Stockholders Re-Elect Directors, Ratify Auditor, and Approve Executive Compensation at Annual Meeting

Phreesia, Inc. announced the results of its annual meeting of stockholders held on June 25, 2025, where all three proposals, including the election of two Class III directors, the ratification of KPMG LLP as its independent auditor, and the advisory approval of executive compensation, were passed.

Summary

• Phreesia, Inc. held its annual meeting of stockholders on June 25, 2025, to vote on three key proposals.
• Stockholders elected Gillian Munson and Mark Smith, M.D. as Class III directors for a three-year term expiring at the 2028 annual meeting.
• Gillian Munson received 47,317,018 votes For and 4,324,384 votes Withheld.
• Mark Smith, M.D. received 37,695,562 votes For and 13,945,840 votes Withheld.
• The appointment of KPMG LLP as the company's independent registered public accounting firm for the fiscal year ending January 31, 2026, was ratified with 53,615,678 votes For, 13,796 votes Against, and 14,903 Abstentions.
• The compensation of the company's named executive officers was approved on a non-binding, advisory basis, with 46,749,876 votes For, 4,874,502 votes Against, and 17,024 Abstentions.

Sentiment

Score: 7

Explanation: The sentiment is generally positive as all proposals passed, indicating stable corporate governance. However, the notable 'against' votes for executive compensation and 'withheld' votes for one director introduce a slight element of shareholder dissent, preventing a higher score.

Positives

• All three proposals presented at the annual meeting were approved by stockholders.
• The re-election of two Class III directors ensures continuity in the board's composition.
• The overwhelming ratification of KPMG LLP as the independent auditor demonstrates strong shareholder confidence in the company's financial oversight.

Negatives

• Mark Smith, M.D. received a significant number of 'Votes Withheld' (13,945,840) for his re-election compared to Gillian Munson, indicating less unanimous support.
• The advisory vote on executive compensation, while passed, saw nearly 4.9 million votes 'Against', suggesting some shareholder dissent regarding executive pay practices.

Future Outlook

The document does not contain specific forward-looking statements or financial guidance beyond the term of the elected directors.

Industry Context

This 8-K filing details routine corporate governance matters for Phreesia, Inc., a healthcare technology company. The outcomes of director elections, auditor ratification, and executive compensation votes are standard annual procedures for publicly traded companies, reflecting internal corporate health rather than broader industry trends or competitive positioning.

Corporate Governance

Stakeholder Impact

• Shareholders: Their votes directly influenced the composition of the board and the appointment of the auditor, and provided advisory feedback on executive compensation.
• Management: The approval of executive compensation, despite some dissent, provides a mandate for current pay structures, while the re-election of directors supports the existing board's direction.
• Employees: No direct impact mentioned, but stable governance can contribute to a stable work environment.

Next Steps

• The newly elected Class III directors, Gillian Munson and Mark Smith, M.D., will serve a three-year term until the company's annual meeting of stockholders in 2028.
• KPMG LLP will continue to serve as the independent registered public accounting firm for the fiscal year ending January 31, 2026.

Key Dates

Keywords

Phreesia, SEC filing, 8-K, annual meeting, stockholders, director election, corporate governance, auditor ratification, executive compensation, KPMG LLP, proxy statement